QHM-2025-7734 A86041.99C..01

The NHS North East and North Cumbria Integrated Care Board is set to award a contract for health services, under the title "QHM-2025-7734 A86041.99C..01". This contract falls within the health services industry category, specifically covering PSA Monitoring, Diabetes Care Planning, Shared Care Drug Monitoring, Care Homes DES - Top Up LES, and Primary Care Investment LES. Located in the UKC region, the procurement process is at the award stage and employs a limited procurement method through Direct Award Process A, pursuant to the Health Care Services (Provider Selection Regime) regulations 2023.

The contract has an active status from 1 April 2025 to 31 March 2026. Notably, this contract does not adhere to the provisions outlined in the Procurement Act 2023 and Procurement Regulations 2024. This tender represents a substantial business opportunity for entities adept in the health services sector, particularly those possessing expertise in diabetes care and home-based health services.

Suitable businesses for this contract are likely to be those with the ability to deliver specialised health care services without competition, due to the absence of viable alternative providers. The current supplier, Swarland Avenue Surgery, located at Benton Road, Newcastle upon Tyne, will be offering these services as part of an established implication contract arrangement. Such opportunities are particularly beneficial for large-scale providers capable of navigating limited procurement scenarios while ensuring quality and cost-effective care solutions.